JNJ vs NCDL · P/E 17, rev $49.37B vs P/E 8.9, $837.2M cap
Johnson & Johnson (JNJ) versus Nuveen Churchill Direct Lending Corp. (NCDL) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Nuveen Churchill Direct Lending Corp. (NCDL) is a asset management company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
NCDL does not have a complete income-statement cache yet.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. NCDL currently screens at market cap $837.2M and trailing P/E 8.9.
Not investment advice. Open the JNJ and NCDL stock pages for the full models.
Not investment advice.